The U.S. in-vitro toxicology testing market size reached USD 12.23 billion in 2025 and is predicted to reach around USD 34.73 billion by 2035, registering a CAGR of 11% from 2026 to 2035. The market is observed to grow rapidly due to major restrictions by the government on animal testing, along with the growing need for faster and predictive safety assessments.

U.S. In-Vitro Toxicology Testing Market Statical Scope

The U.S. in-vitro toxicology testing market is also expected to grow due to higher investments in research and development for early toxicity detection. 3D cell culture technologies are also helping to fuel the market's growth as they help to mimic human psychology more accurately than 2D culture.

U.S. In-Vitro Toxicology Testing Market Share, By Technolog, 2025 (%)

• Cell Culture Technology- The segment dominates with 35% of the market share and is driven by its strong application in toxicity screening and ability to stimulate human biological responses in controlled laboratory environments.
• High-Throughput Technology- The segment has a notable share of 30% and is growing due to its need for faster and scalable toxicity testing processes.

U.S. In-Vitro Toxicology Testing Market Share, By Product, 2025 (%)

• Consumables- The segment holds 30% of the market share and is growing due to its recurring usage in testing workflows and recurring demand.
• Assays- The segment has 25% of the market share and is supported by its essential role in detecting and analyzing toxicological responses.

U.S. In-Vitro Toxicology Testing Market, By Method Share, By Solution, 2025 (%)

• Cellular Assay- The segment has a significant share of 40% and is growing due to its widespread use in evaluating toxicity at the cellular level.
• Biochemical Assay- The segment accounts for 30% of the market share and is propelling due to its role in analyzing biochemical pathways and toxicity mechanisms.

U.S. In-Vitro Toxicology Testing Market, By Application Market Share, By Solution, 2025 (%)

• Systemic Toxicology- The dominating segment holds 30% of the market share and is driven by the need to assess overall toxic effects on human health.
• Dermal Toxicity- The segment accounts for 20% of the market share and is progressing due to increasing safety testing requirements in cosmetic and skincare products.

U.S. In-Vitro Toxicology Testing Market, By End Use Market Share, By Solution, 2025 (%)

• Pharmaceutical Industry- The dominating segment holds 35% of the market share and is driven by strong demand for drug safety testing and regulatory compliance.
• Skincare and Household Products- The segment has 15% of the market share and is progressing due to the growing adoption of non-animal testing methods.

Top Companies in the U.S. In-Vitro Toxicology Testing Market

• Charles River Laboratories International, Inc.
• SGS S.A.
• Merck KGaA
• Eurofins Scientific
• Abbott Laboratories
• Laboratory Corporation of America Holdings
• Evotec S.E.
• Thermo Fisher Scientific, Inc.
• Quest Diagnostics Incorporated
• Agilent Technologies, Inc.
• Catalent, Inc.
• Danaher Corporation
• Bio-Rad Laboratories, Inc.
• BioIVT
• Gentronix

Segments Covered in the Report

By Technology

• Cell Culture Technology
• High Throughput Technology
• Molecular Imaging Technology
• OMICS Technology

By Product

• Consumables
• Assays
• Instruments
• Software
• Services

By Method

• Cellular Assay
• Live Cells
• High Throughput / High Content Screening
• Molecular Imaging
• Confocal Microscopy
• Others
• Others
• Fixed Cells
• Biochemical Assay
• In Silico
• Ex-vivo

By Application

• Systemic Toxicology
  • Acute Toxicity
  • Carcinogenicity
  • Developmental Toxicity
  • Others
• Dermal Toxicity
  • Skin Irritation Test
  • Skin Sensitization Test
  • Skin Corrosion Test
  • Phototoxicity Test
  • Others
• Endocrine Disruption
  • Dioxins
  • Phthalates
  • Polychlorinated biphenyls (PCB)
  • Ocular Toxicity
  • Intravitreal
  • Subretinal
  • Others
• Others
  • Immunotoxicity
  • Reproductive Toxicity
  • Neurotoxicity
  • Epigenetic Alterations
  • Genotoxicity
  • Others

By End-use

• Pharmaceutical Industry
• Cosmetics & Household Products
• Academic Institutes & Research Laboratories
• Diagnostics
  • Medical Devices
  • Others
• Chemicals Industry
• Food Industry